Effect of acute and chronic administration of buspirone on serotonin and benzodiazepine receptor subtypes in the rat brain: An autoradiographic study

[1]  M. Gobbi,et al.  Regional distribution of low-affinity GABA receptors coupled to benzodiazepine receptor subtypes in rat brain: an autoradiographic evaluation. , 1990, European journal of pharmacology.

[2]  S. Garattini,et al.  Effect of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine on hippocampal serotoninergic system, studied in freely moving rats. , 1990, Life sciences.

[3]  B. Longoni,et al.  Functional coupling of GABAA receptors and benzodiazepine recognition site subtypes in the spinal cord of the rat. , 1989, European journal of pharmacology.

[4]  P. Seeburg,et al.  Type I and type II GABAA-benzodiazepine receptors produced in transfected cells. , 1989, Science.

[5]  Duncan P. Taylor.  Buspirone, a new approach to the treatment of anxiety , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  J. Palacios,et al.  Benzodiazepine receptor sites in the human brain: Autoradiographic mapping , 1988, Neuroscience.

[7]  D. Hoyer.  Functional correlates of serotonin 5-HT1 recognition sites. , 1988, Journal of receptor research.

[8]  L. Cervo,et al.  Potential antidepressant properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist. , 1987, European journal of pharmacology.

[9]  K. Rickels,et al.  Gepirone in Anxiety: A Pilot Study , 1987, Journal of clinical psychopharmacology.

[10]  C. de Montigny,et al.  Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brain , 1987, Synapse.

[11]  S. Garattini,et al.  Mechanism of action of anxiolytic drugs. , 1987, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[12]  C. P. Vandermaelen,et al.  Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. , 1986, European journal of pharmacology.

[13]  S. Garattini,et al.  1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat. , 1986, Pharmacology.

[14]  M. Gobbi,et al.  Neurochemical effects of buspirone in rat hippocampus: evidence for selective activation of 5HT neurons. , 1986, Archives internationales de pharmacodynamie et de therapie.

[15]  J. Palacios,et al.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.

[16]  B. Goldstein,et al.  Comparison of Buspirone and Diazepam in Generalized Anxiety Disorder , 1985, Pharmacotherapy.

[17]  M. Hamon,et al.  Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. , 1985, European journal of pharmacology.

[18]  S. Iversen.  5-HT and anxiety , 1984, Neuropharmacology.

[19]  S. Hjorth,et al.  Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). , 1984, European journal of pharmacology.

[20]  S. Paul,et al.  Behavioral and neurochemical studies on the anticonflict actions of buspirone , 1984 .

[21]  S. Garattini,et al.  Dopaminergic effects of buspirone, a novel anxiolytic agent. , 1983, Biochemical pharmacology.

[22]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[23]  J. Feighner,et al.  A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder. , 1982, The Journal of clinical psychiatry.

[24]  M. Eison,et al.  Pharmacology and neurochemistry of buspirone. , 1982, The Journal of clinical psychiatry.

[25]  K. Weisman,et al.  Buspirone and diazepam in anxiety: a controlled study. , 1982, The Journal of clinical psychiatry.

[26]  H. L. Goldberg,et al.  The comparative efficacy of buspirone and diazepam in the treatment of anxiety. , 1979, The American journal of psychiatry.